Abstract
The steroids are a group of compounds containing a four-ring structure termed the cyclopentanoperhydrophenanthrene nucleus (Fig. 1). As shown in Fig. lb, the nucleus itself is composed of 17 carbon atoms; however, the synthesis of the steroid hormones involves the addition of one, two, or four additional carbon atoms to form the CI8 estranes, C19 androstanes, and C21 pregnanes, respectively (Fig. 2). The CI8 steroids include estradiol, estrone, and estriol. Estradiol is synthesized mainly in the ovary, with transformation to estrone and estriol taking place in the liver. Some synthesis also occurs in the adrenal as well as in the testis. Testosterone and dihydrotestosterone are examples of the C19 steroids. The major synthesis of testosterone occurs in the testis; however, androgen production has also been shown to occur in the adrenal and the ovary. The C21 steroids are produced mainly in the adrenal gland and include progesterone (also synthesized by the ovary), the glucocorticoids such as Cortisol, and the mineralocorticoids such as aldosterone.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alberga A, Tran A, Baulieu EE (1979) Distribution of estradiol receptor and vitellogenin gene in chick liver chromatin fractions. Nucleic Acids Res 7:2031–2044
Allegra JC, Lippman ME, Simon R, Thompson EB, Barlock A, Green L, Huff KK, Do HMT, Aitken S, Warren R (1979 a) Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treat Rep 63:1271–1277
Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken S (1979 b) Distribution, frequency and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 39:1447–1454
Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken SC, Warren R (1979 c) Relationship between the progesterone, androgen and glucocorticoid receptor response rate to endocrine therapy in metastatic breast cancer. Cancer Res 39:1973–1979
Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken S, Warren R (1980) Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. Eur J Cancer 16:323–331
Allera A, Rao GS, Breuer H (1980) Specific interactions of corticosteroids with components of the cell membrane which are involved in the translocation of the hormone into the intravesicular space of purified rat liver plasma membrane vesicles. J Steroid Biochem 12:259–266
Asselin J, Kelly PA, Caron MG, Labrie F (1977) Control of hormone receptor levels and growth of 7,12-dimethylbenz[a]anthracene-induced mammary tumors by estrogens, progesterone and prolactin. Endocrinology 101:666–671
Barrack ER, Coffey DS (1980) The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues. J Biol Chem 255:7265–7275
Baxter JD, Rousseau GG, Benson MC, Garcea RL, Ito J, Tomkins GM (1972) Role of DNA and specific cytoplasmic receptors in glucocorticoid action. Proc Natl Acad Sci 69:1892–1896
Behrens UJ, Hollander VP (1976) Cell membrane sialoglycopeptides of corticoid-sensitive and -resistant lymphosarcoma P1798. Cancer Res 36:172–180
Behrens UJ, Mashburn LT, Stevens J, Hollander VP, Lampen N (1974) Differences in cell surface characteristics between glucocorticoid-sensitive and resistant mouse lymphomas. Cancer Res 34:2926–2932
Bell PA, Sloman JC, Whittaker J A (1979) Glucorticoid receptors in myeloid leukemia. Cancer Treat Rep 63:1197
Bhakoo HS, Katzenellenbogen BS (1977) Progesterone modulation of estrogen-stimulated uterine biosynthetic events and estrogen receptor levels. Mol Cell Endocrinol 8:121–134
Bishop HM, Elston CW, Blarney RW, Haybittle JL, Nicholson RI, Griffiths K (1979) Relationship of estrogen receptor status to survival in breast cancer. Lancet 2:283–284
Bloom ND, Tobin EH, Schreibman B, Degenshein GA (1980) The role of progesterone in the management of advanced breast cancer. Cancer 45:2992–2997
Bloomfield CD, Peterson BA, Zaleskas J, Frizzerà G, Smith KA, Hildebrandt L, Gajl-Peczalska J, Munck A (1980) In vitro studies for predicting glucocorticoid therapy in adults with malignant lymphoma. Lancet 1:952–955
Bonadonna G, Valagussa P, Tancini G, DiFronzo G (1980) Estrogen receptor status and response to chemotherapy in early and advanced breast cancer. Cancer Chemother Pharmacol 4:37–41
Bourgeois S, Newby RF (1977) Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell 11:423–430
Bourgeois S, Newby RF (1979) Correlation between glucocorticoid receptor and cytolytic response of murine lymphoid cell lines. Cancer Res 39:4749–4751
Bourgeois S, Newby RF, Huet M (1978) Glucocorticoid resistance in murine lymphoma and thymoma lines. Cancer Res 38:4279–284
Cake MH, DiSorbo DM, Litwack G (1978) Effect of pyridoxal phosphate on the DNA binding site of activated hepatic glucocorticoid receptor. J Biol Chem 253:4886–4891
Carter SK (1978) Acute lymphocytic leukemia. In: Staquet MJ (ed) Randomized trials in cancer: a critical review by sites. Raven, New York, pp 1–24
Chang E, Mittelman A, Rosen F (1964) The metabolism in vitro of [4-14C] cortisone by lymphosarcoma P1798. Biochim Biophys Acta 90:600–605
Cheix F, Biron A, Bailly C, Mayer M, Pommatau E, Saez S (1980) Cancer du sein operable: valeur prognostique du nombres des recepteurs d’estradiol. Nouv Presse Med 9:933— 935
Cidlowski J A, Munck A (1980) Differential solubilization of nuclear glucocorticoid receptors by DNAse I and DNAse II. Biochim Biophys Acta 630:375–385
Cline MJ (1974) Adrenal steroids in leukemia and lymphoma. Cancer Chemotherapy Rep 58 (part l):521–525
Crabtree GR, Smith KA, Munck A (1978) Glucocorticoid receptors and sensitivity of isolated human leukemia and lymphoma cells. Cancer Res 38:4268–272
Davis JM, Chan AK, Thompson EA (1980) Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma PI 798. J Natl Cancer Inst 64:55–62
Debusscher L, Stryckmans PA (1978) Nonlymphocytic acute leukemia. In: Staquet MJ (ed), Randomized trials in cancer: a critical review by sites. Raven, New York, p 25–54
DiCarlo F, Reboani C, Conti G, Genazzani E (1978) Changes in the concentration of uterine cytoplasmic oestrogen receptors induced by doxorubicin and methotrexate. J Endocrinol 79:201–208
DiCarlo R, Muccioli G, Conti G, Reboani C, DiCarlo F (1980 a) Estrogen and prolactin receptor concentrations in human breast tumors. In: Genazzani E, DiCarlo F, Mainwaring WIP (eds) Pharmacological modulation of steroid action, Raven, New York, pp 261–266
DiCarlo F, Reboani C, Conti G, Portaleone P, Viano I, Genazzani E (1980 b) Changes in estrogen receptor levels induced by pharmacological agents. In: Genazzani E, DiCarlo F, Mainwaring WIP (eds) Pharmacological modulation of steroid action. Raven, New York, pp 61–74
DiSorbo DM, Phelps DS, Litwack G (1980 a) Chemical probes of amino acid residues affect the active sites of the glucocorticoid receptor. Endocrinology 106:922–929
DiSorbo DM, Phelps DS, Ohi VS, Litwack G (1980 b) Pyridoxine deficiency influences the behavior of the glucocorticoid receptor complex. J Biol Chem 255:3866–3870
Edwards DP, Adams DJ, Savage N, McGuire WL (1980 a) Estrogen induced synthesis of specific proteins in human breast cancer cells. Biochim Biophys Acta 93:804–812
Edwards DP, Martin PM, Horwitz KB, Chamness GC, McGuire WL (1980 b) Subcellular compartmentalization of estrogen receptors in human breast cancer cells. Exp Cell Res 127:197–213
Fazekas AG, MacFarlane JK (1977) Macromolecular binding of glucocorticoids in human mammary carcinoma. Cancer Res 37:640–645
Fazekas AG, MacFarlane JK (1980) Studies on cytosol and nuclear binding of estradiol in human breast cancer. J Steroid Biochem 13:613–622
Fessas P, Wintrobe MM, Thompson RB, Cartwright GE (1954) Treatment of acute leukemia with cortisone and corticotropin. Arch Int Med 94:384–401
Fisher ER, Redmond CK, Liu H, Rockette H, Fisher B (1980) Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer 45:349–353
Gailani S, Minowada J, Silvernail P, Nussbaum A, Kaiser N, Rosen F, Shimaoka K (1973) Specific glucocorticoid binding in human hemopoietic cell lines and neoplastic tissue. Cancer Res 33:2653–2657
Garola RE, McGuire WL (1977) An improved assay for nuclear estrogen receptor in experimental and human breast cancer. Cancer Res 37:3333–3337
Gehring U (1978) Genetic analysis of glucocorticoid action in neoplastic lymphoid cells. AdvEngRegul 17:343–361
Gehring U, Tomkins GM (1974) A new mechanism for steroid unresponsiveness: loss of nuclear binding activity of a steroid hormone receptor. Cell 3:301–306
Geier A, Ginzburg R, Stauber M, Lunenfeld B (1979) Unoccupied binding sites for oestra-diol in nuclei from human breast carcinomatous tissue. J Endocrinol 80:281–288
Gottesfeld JM, Butler PJG (1977) Structure of transcriptionally active chromatin subunits. Nucleic Acids Res 4:3155–3173
Granville NB, Rubio F Jr, Unugur A, Schulman E, Dameshek W (1958) Treatment of acute leukemia in adult with massive doses of prednisone and prednisolone. New Engl J Med 259:207–213
Hahnel R, Woodings T, Vivian AB (1979) Prognostic value of estrogen receptors in primary breast cancer. Cancer 44:671–675
Hahnel R, Partridge RK, Gavet L, Twaddle E, Ratajczak T (1980) Nuclear and cytoplasmic estrogen receptors and progesterone receptors in breast cancer. Eur J Cancer 16:1027–1033
Harrison RW, Fairfield S, Orth DN (1974) Evidence for glucocorticoid transport through the target cell membrane. Biochem Biophys Res Comm 61:1262–1267
Harrison RW, Fairfield S, Orth DN (1975) Evidence for glucocorticoid transport into AtT- 20/D-l cells. Biochemistry 14:1304–1307
Harrison RW, Fairfield S, Orth DN (1977) The effect of cell membrane alteration on glucocorticoid uptake by the AtT-20/D-l target cell. Biochim Biophys Acta 466:357–365
Hawkins RA, Roberts MM, Forrest APM (1980) Oestrogen receptors and breast cancer: current status. Br J Surg 67:153–169
Hemminki K (1976) Distribution of estrogen receptors in subfractions of hen oviduct chromatin. Nucleic Acids Res 3:1499–1506
Hemminki K (1977) Differential distribution of oestrogen receptors in subfractions of oviduct chromatin. Acta Endocrinol 84:215–224
Henderson ES (1973) Acute lymphoblastic leukemia. In: Holland JF, Frei E (eds) Cancer medicine. Lea and Febiger, Philadelphia, pp 1173–1199
Hendrick D, Tolstoshev P, Randlett D (1977) Enrichment for the globin coding region in a chromatin fraction from chick reticulocytes by endonuclease digestion. Gene 2:147–158
Higgins SJ, Rousseau GG, Baxter JD, Tomkins GM (1973) Nature of nuclear acceptor sites for glucocorticoid-and estrogen-receptor complexes. J Biol Chem 248:5873–5879
Higgins SJ, Baxter JD, Rousseau GG (1979) Nuclear binding of glucocorticoid receptors. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action, Springer, Berlin Heidelberg New York, pp 135–160
Hilf R, Feldstein ML, Gibson SL, Savlov ED (1980) The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Cancer 45:1993–2000
Holdaway IM, Friesen HG (1977) Hormone binding by human mammary carcinoma. Cancer Res 37:1946–1952
Hollander N, Chiu Y-W (1966 a) Relation between Cortisol metabolism and its lympholytic effect in PI978 lymphosarcoma. Endocrinology 79:168–174
Hollander N, Chiu Y-W (1966 b) In vitro binding of Cortisol -1,2-3H by a substance in the supernatant fraction of P1798 mouse lymphosarcoma. Biochem Biophys Res Comm 25:291–297
Horwitz KB, McGuire WL (1978) Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem 253:2223–2228
Horwitz KB, McGuire WL, Pearson OH, Segaloff A (1975) Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science 189:726–727
Ho AD, Hunstein W, Schmid W (1980) Determination of glucocorticoid receptors in human leukemias. Klin Wochenschr 58:43–45
Homo F, Duval D, Meyer P, Belas F, Debre P, Binet J-L (1978) Chronic lymphatic leukemia: cellular effects of glucocorticoid in vitro. Br J Haemat 38:491–499
Homo F, Duval D, Harousseau JL, Marie JP, Zittoun R (1980) Heterogeneity of the in vitro response to glucocorticoids in acute leukemia. Cancer Res 40:2601–2608
Horibata K, Harris AW (1970) Mouse myelomas and lymphomas in culture. Exp Cell Res 60:61–77
Hsueh AWJ, Peck EJ, Clark JH (1976) Control of uterine estrogen receptor levels by progesterone. Endocrinology 98:438–444
Ip MM, Milholland RJ, Rosen F, Kim U (1979) Mammary cancer: selective action of the estrogen receptor complex. Science 203:361–363
Ip MM, Milholland RJ, Rosen F (1980) Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma. Cancer Res 40:2188–2193
Ip MM, Milholland RJ, Rosen F, Kim U (1981) Dichotomous effects of tamoxifen on a transplantable rat mammary tumor. Cancer Res 41:984–988
Jensen EV (1975) Estrogen receptors in hormone-dependent breast cancers. Cancer Res 35:3362–3364
Jensen EV, DeSombre ER, Jungblut PW (1967) Estrogen receptors in hormone responsive tissues and tumors. In: Wissler RW, Dao TL, Wood SJ Jr (eds) Endogenous factors influencing host-tumor balance. University of Chicago Press, Chicago, pp 15–30
Jonat W, Maass H (1978) Some comments on the necessity of receptor determination in human breast cancer. Cancer Res 38:4305–306
Jordan VC, Dowse LJ (1976) Tamoxifen as an antitumor agent: effect on oestrogen binding. J Endocrinol 68:297–303
Kaiser N, Milholland RJ, Rosen F (1974) Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798. Cancer Res 34:621–626
Katzenellenbogen BS (1978) Basic mechanisms of antiestrogen action. In: McGuire WL (ed) Hormones, receptors and breast cancer. Raven, New York, pp 135–157
Katzenellenbogen BS, Bhakoo HS, Hayes JR, Schmidt WN (1980) Uterine estrogen-induced protein: an index of uterine sensitivity to hormones. In: Beato M (ed) Steroid induced proteins, Elsevier, North Holland Biomedical, Amsterdam, pp 267–281
Kiang DT (1977) Nuclear oestrogen receptor and breast cancer. Lancet 2:714–715
Kiang DT, Frenning DH, Goldman AI, Ascensao VF, Kennedy BJ (1978) Estrogen receptors and response to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med 299:1330–1334
Kim U, Depowski MJ (1975) Progression from hormone dependence to autonomy in mammary tumors as an in vivo manifestation of sequential clonal selection. Cancer Res 35:2068–2077
King RJB, Redgrave S, Rubens RD, Millis R, Hayward JA (1978) Cited by WL McGuire in: Steroid receptors in human breast cancer. Cancer Res 38:4289–291
Kirkpatrick AF, Kaiser N, Milholland RJ, Rosen F (1972) Glucocorticoid-binding macro-molecules in normal tissue and tumors: stabilization of the specific binding component. J Biol Chem 247:70–74
Kirkpatriek AF, Milholland RJ, Rosen F (1971) Stereospeeifie glucocorticoid binding to subcellular fractions of the sensitive and resistant lymphosarcoma PI 798. Nature (New Biol) 232:216–218
Kisling S, Adler VV, Dmitneva LY, Shapot VS (1979) The existence of specific receptors for glucocorticoid on the plasma membranes of the rat liver. Biochemistry (Biokhimiia) 44:1600–1604
Knight WA, Livingston RB, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37:4669–4671
Konior GS, Lippman ME, Johnson GE, Leventhal BG (1977 a) Correlation of glucocorticoid receptor levels and complete remission duration in “poor prognosis” acute lymphatic leukemia. Proc Am Soc Clin Oncol 18:353
Konior GS, Lippman ME, Johnson GE, Owens AH, Leventhal BG (1977 b) Glucocorticoid receptors in acute non-lymphocytic leukemia. Proc Am Assoc Cancer Res 18:235
Konior-Yarbro GS, Lippman ME, Johnson GE, Leventhal BG (1977) Glucocorticoid receptors in subpopulations of childhood acute lymphocytic leukemia. Cancer Res 37:2688–2695
Laing L, Caiman KC, Smith MG, Smith DC, Reake RE (1977) Nuclear oestrogen receptors and treatment of breast cancer. Lancet 2:168–169
Lampkin JM, Potter M (1958) Response to cortisone and development of cortisone resistance in a cortisone-sensitive lymphosarcoma of the mouse. J Natl Cancer Inst 20:1091–1111
Lampkin-Hibbard JM (1966) Lymphomas: Regression, carcinogenesis and prevention. LS Haines, Miami
Leclercq G, Heuson JC (1977) Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer. Eur J Cancer 13:1205–1215
Leclercq G, Heuson JC (1980) Estrogen-linked cytotoxic agents of potential value for the treatment of breast cancer: binding affinity for estrogen receptors. In: Genazzani E, DiCarlo F and Mainwaring WIP (eds) Pharmacological modulation of steroid action, Raven, New York, pp 217–226
Lee SH (1979) Cancer cell estrogen receptor of human mammary carcinoma. Cancer 44:1–12
Levy-Wilson B, Baxter JD (1976) Distribution of thyroid and glucocorticoid hormone receptors in transcriptionally active and inactive chromatin. Biochem Biophys Res Comm 68:1045–1051
Lippman ME, Halterman RH, Leventhal BG, Perry S, Thompson EB (1973) Glucocorticoid-binding proteins in human acute lymphoblastic leukemic blast cells. J Clin Invest 52:1715–1725
Lippman ME, Perry S, Thompson EB (1975) Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia. Am J Med 59:224–227
Lippman ME, Allegra JC, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken S, Warren R (1978) The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med 298:1223–1228
Maass H, Engel B, Trams G, Nowakowski H, Stolzenbach G (1975) Steroid hormone receptors in human breast cancer and the clinical significance. J Steroid Biochem 6:743–749
Mainwaring WIP, Symes EK, Higgins SJ (1976) Nuclear components responsible for the retention of steroid-receptor complexes, especially from the standpoint of the specificity of hormonal responses. Biochem J 156:129–141
Marsland TA, Rosenbaum C, Stolbach LL, Cohen JL (1979) Estrogen receptors and chemotherapy in breast cancer. Proc Am Soc Clin Oncol 20:367
Martin PM, Rolland PH, Jacquemier J, Rolland AM, Toga M (1979) Multiple steroid receptors in human breast cancer. III. Relationships between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features. Cancer Chemotherap Pharmacol 2:115–120
Massol N, Lebeau M-C, Baulieu E-E (1978) Estrogen receptor in hen oviduct chromatin digested by micrococcal nuclease. Nucleic Acids Res 5:723–738
Mayer M, Nir S, Milholland RJ, Rosen F (1976) Effect of temperature on glucocorticoid uptake and glucocorticoid-receptor translocation in rat thymocytes. Arch Biochem Biophys 176:28–36
Maynard PV, Davies CJ, Blarney RW, Elston CW, Johnson J, Griffiths K (1978) Relationship between oestrogen-receptor content and histological grade in human primary breast tumors. Br J Cancer 38:745–748
McGuire WL (1978) Steroid receptors in human breast cancer. Cancer Res 38:4289–1291
McGuire WL (1980) Steroid hormone receptors in breast cancer treatment strategy. Recent Prog Horm Res 36:135–146
McGuire WL, Carbone PP, Sears ME, Escher GC (1975) Estrogen receptors in human breast cancer: an overview. In: McGuire WL, Carbone PP, Vollmer EP (eds) Estrogen receptors in human breast cancer. Raven, New York, pp 1–7
McGuire WL, Horwitz KB, Zava DT, Garola RE, Chamness GC (1978) Hormones in breast cancer: update 1978. Metabolism 27:487–501
McPartland RP, Milholland RJ, Rosen F (1977) Nuclear binding of steroid-receptor complex to lymphosarcoma PI798 resistant and sensitive cells and effect of concanavalin A on receptor levels. Cancer Res 37:4256–4260
Meyer JS, Lee JY (1980) Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness and duration of survival. Cancer Res 40:1890–1896
Meyer JS, Bauer WC, Rao BR (1978) Subpopulations of breast carcinoma defined by S-phase fraction, morphology and estrogen receptor content. Lab Invest 39:225–235
Milgrom E, Atger M, Bailly A (1976) Interaction of rat liver glucocorticoid receptor with DNA. Eur J Biochem 70:1–6
Milholland RJ, Ip MM, Rosen F (1979) The effect of hydrocortisone treatment on the in vivo phosphorylation of a subgroup of non-histone nuclear proteins in the mouse lymphosarcoma PI798. Biochem Biophys Res Comm 88:993–997
Morgan L, Laggatt PR, DeSouza I, Salih H, Hobbs JR (1977) Prolactin receptors in human breast tumors. J Endocrinol 73:17P
Muller RE, Sheard BE, Traish A, Wotiz HH (1980) Effect of chemotherapeutic agents on the formation of estrogen receptor complex in human breast tumor cytosol. Cancer Res 40:2941–2942
Nicholson ML, Young DA (1978) Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798. Cancer Res 38:3673–3680
Nicholson ML, Young DA (1979) Independence of the lethal actions of glucocorticoids on lymphoid cells from possible hormone effects on calcium uptake. J Supramol Struct 10:165–174
Nicholson ML, Voris BP, Young DA (1979) Lethal actions of glucocorticoids in lymphoid cells: a protein associated with emergence of the resistant state. Cancer Treat Rep 63:1196
Nomura Y, Yamagata J, Kondo H (1979) Significance of estrogen receptor assay in cytotoxic chemotherapy in relation to previous endocrine therapy of advanced breast cancer patients. Gann 70:473–482
Nomura Y, Takatani O, Sugano H, Matsumoto K (1980) Oestrogen and progesterone receptors and response to endocrine therapy in Japanese breast cancer. J Steroid Biochem 13:565–566
Panko WB, MacLeod RM (1978) Uncharged nuclear receptors for estrogen in breast cancers. Cancer Res 38:1948–1951
Pari FF, Wagner RK (1980) The histological evaluation of human breast cancers in correlation with estrogen receptor values. Cancer 46:362–367
Partridge RK, Hahnel R (1979) Prolactin receptors in human breast carcinoma. Cancer 43:643–646
Pearson OH, Eliel LP (1950) Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias. JAMA 144:1349–1353
Persijn JP, Korsten CB, Engelsman E (1975) Oestrogen and androgen receptors in breast cancer and response to endocrine therapy. Br Med J 4:503
Pfahl M, Kelleher RJ, Bourgeois S (1978) General features of steroid resistance in lymphoid cell lines. Mol Cell Endocrinol 10:193–207
Plagemann PGW, Erbe J (1976) Glucocorticoids - uptake by simple diffusion by cultured Reuber and Novikoff rat hepatoma cells. Biochem Pharmacol 25:1489–1494
Puca GA, Nola E, Hibner U, Cicala G, Sica V (1975) Interaction of the estradiol receptor from calf uterus with its nuclear acceptor sites. J Biol Chem 250:6452–6459
Raina PN, Rosen F (1969) Selective effect of Cortisol on deoxyribonuclease II activity of lymphosarcoma P1798. Arch Int Pharmacodyn 182:14–23
Ranney HM, Gellhorn A (1957) The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas. Am J Med 22:405–413
Rao BR, Wiest WG (1971) Estradiol-17/? stimulation of progesterone binding in rabbit uterus (abstract). Fed Proc 30:1213
Rao ML, Rao GS, Holler M, Breuer H, Schattenberg PJ, Stein WD (1976) Uptake of Cortisol by isolated rat liver cells. A phenomenon indicative of carrier-mediation and simple diffusion. Hoppe Seylers Z Physiol Chem 357:573–584
Rao ML, Rao GS, Eckel J, Breuer H (1977) Factors involved in uptake of corticosterone by rat liver cells. Biochim Biophys Acta 500:322–332
Rich MA, Furmanski P, Brooks SC (1978) Prognostic value of estrogen receptor determinations in patients with breast cancer. Cancer Res 38:4296–4298
Roath S, Israels MCG, Wilkinson JF (1964) The acute leukemias: a study of 580 patients. Q J Med 33:257–283
Rochefort H, Garcia M (1976) Androgen on the estrogen receptor: I. Binding and in vivo nuclear translocation. Steroids 28:549–560
Romic-Stojkovic R, Gamulin S (1980) Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer. Cancer Res 40:4821–4825
Rosen JM, Fina JJ, Milholland RJ, Rosen F (1970 a) Inhibition of glucose uptake in lymphosarcoma P1798 by Cortisol and its relationship to the biosynthesis of deoxyribonucleic acid. J Biol Chem 245:2074–2080
Rosen JM, Rosen F, Milholland RJ, Nichol CA (1970b) Effects of Cortisol on DNA metabolism in the sensitive and resistant lines of mouse lymphoma P1798. Cancer Res 30:1129–1136
Rosen JM, Fina JJ, Milholland RJ, Rosen F (1972) Inhibitory effect of Cortisol in vitro on 2-deoxyglucose uptake and RNA and protein metabolism in lymphosarcoma PI798. Cancer Res 32:350–355
Rosner D, Nemoto T (1979) A randomized study of 2 and 3 drug regimen in relation with estrogen receptors in metastatic breast cancer. Proc Am Assoc Cancer Res 20:46
Rubens RD, King RJB, Sexton S, Minton MJ, Hayward JL (1980) Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer. Cancer Chemother Pharmacol 4:43–45
Ruh TS, Wassilak SG, Ruh MF (1975) Androgen-induced nuclear accumulation of the estrogen receptor. Steroids 25:257–273
Samal B, Singhakowinta H, Brooks SC, Vaitkevicius VK (1978) Estrogen receptors and response of breast cancer to chemotherapy. N Engl J Med 299:604
Samuels HH, Tomkins GM (1970) Relation of steroid structure to enzyme induction in hepatoma tissue culture cells. J Mol Biol 52:57–74
Schmidt TJ, Thompson EB (1978) Glucocorticoid receptor function in leukemic cells. In: Sharma RK, Criss WE (eds) Endocrine control in neoplasia. Raven, New York, pp 263–290
Schmidt TJ, Harmon JM, Thompson EB (1980) “Activation-labile” glucocorticoid-receptor complexes of a steroid-resistant variant of CEM-C7 human lymphoid cells. Nature 286:507–510
Schmidt WN, Sadler MA, Katzenellenbogen BS (1976) Androgen-uterine interaction: nuclear translocation of the estrogen receptor and induction of the synthesis of the uterine-induced protein (IP) by high concentrations of androgens in vitro but not in vivo. Endocrinology 98:702–716
Scott RW, Frankel FR (1980) Enrichment of estradiol-receptor complexes in a transcriptionally active fraction of chromatin from MCF-7 cells. Proc Natl Acad Sci 77:1291–1295
Shanbrom E, Miller S (1962) Critical evaluation of massive steroid therapy of acute leukemia. N Engl J Med 266:1354–1358
Sherman MR, Corval PL, O’Malley BW (1970) Progesterone-binding components of chick oviduct. I. Preliminary characterization of cytoplasmic components. J Biol Chem 245:6085–6096
Sibley CH, Yamamoto KR (1979) Mouse lymphoma cells: mechanisms of resistance to glucocorticoids. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, pp 357–376
Silfversward C, Gustafsson JA, Gustafsson SA, Humla S, Nordenskjold B, Wallgren A, Wrange O (1980) Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer. Cancer 45:2001–2005
Silvestrini R, Daidone MG, DiFronzo G (1979) Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer 44:665–670
Simons Jr SS (1979) Factors influencing association of glucocorticoid receptor-steroid complexes with nuclei, chromatin and DNA: interpretation of binding data. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action, Springer, Berlin Heidelberg New York, pp 161–187
Skinner LG, Barnes DM, Ribeiro GG (1978) Cited by WL McGuire in Steroid receptors in human breast cancer. Cancer Res 38:4289–4291
Socher SH, Krall JF, Jaffee RC, O’Malley BW (1976) Distribution of binding sites for the progesterone receptor within chick oviduct chromatin. Endocrinology 99:891–900
Spelsberg TC, Thrall C, Webster R, Pikler G (1977) Isolation and characterization of the nuclear acceptor that binds the progesterone-receptor complex in hen oviduct. J Toxicol Environ Health 3:309–337
Stevens J, Stevens YW (1979) Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798. Cancer Res 39:4011–1021
Stevens J, Stevens YW, Hollander VP (1974) Substrate requirements and kinetic analysis of the Cortisol effects on uridine uptake and incorporation by mouse lymphoma P1798 cells in vitro. Cancer Res 34:2330–2337
Stevens J, Stevens YW, Rhodes J, Steiner G (1978) Differences in nuclear glucocorticoid binding between corticoid-sensitive and corticoid-resistant lymphocytes of mouse lymphoma P1798 and stabilization of nuclear hormone receptor complexes with carbobenzyoxy-L-phenylalanine. J Nat Cancer Inst 61:1477–1485
Stevens J, Stevens YW, Rosenthal RL (1979) Characterization of cytosolic and nuclear glucocorticoid binding components in human leukemic lymphocytes. Cancer Res 39:4939–4948
Terenius L, Simonsson B, Nilsson K (1976) Glucocorticoid receptors, DNA synthesis, membrane antigens and their relation to disease activity in chronic lymphatic leukemia. J Steroid Biochem 7:905–909
Teulings FAG, van Gilse HA, Henkelman MS, Portengen H, Alexieva-Figusch J (1980) Estrogen, androgen, glucocorticoid and progesterone receptors in progestin-induced regression of human breast cancer. Cancer Res 40:2557–2561
Thompson EA, Moore WM, Sawyer RH (1980) Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice. J Natl Cancer Inst 65:477–483
Thompson EB (1979) Report on the International Union against Cancer Workshop on steroid receptors in leukemia. Cancer Treat Rep 63:189–195
Thorsen T (1979) Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: relation to oestradiol and progesterone cytosol receptors. J Steroid Biochem 10:661–668
Thrall CL, Spelsberg TC (1980) Factors affecting the binding of chick oviduct progesterone receptor to deoxyribonucleic acid: evidence that deoxyribonucleic acid alone is not the nuclear acceptor site. Biochemistry 19:4130–1138
Toft DO, O’Malley BW (1972) Target tissue receptors for progesterone: the influence of estrogen treatment. Endocrinology 90:1041–1045
Tsai T-LS, Katzenellenbogen BS (1977) Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U23, 469, and effects on estrogen and progesterone receptors. Cancer Res 37:1537–1543
Turnell RW, Burton AF (1974) Studies on the mechanism of resistance to lymphocytolysis induced by,corticosteroids. Cancer Res 34:39–42
Turnell RW, Burton AF (1975) Glucocorticoid receptors and lymphocytolysis in normal and neoplastic lymphocytes. Mol Cell Biochem 9:175–189
Turnell RW, Clarke LH, Burton AF (1973) Studies on the mechanism of corticosteroid-induced lymphocytolysis. Cancer Res 33:203–212
Voris BP, Nicholson ML, Young DA (1979) Resistance to lethal effects of glucocorticoids: increased synthesis of the same proteins may be responsible for the emergence of resistance in PI798 mouse lymphosarcoma and normal rat thymus cells. Fed Proc 38:512
Wagner RK, Gorlich L, Jungblut PW (1973) Dihydrotestosterone receptor in human mammary cancer. Acta Endocrinol [Suppl] 173:65
Walt AJ, Singhakowinta A, Brooks SC, Cortez A (1976) The surgical implications of estrophile protein estimations in carcinoma of the breast. Surgery 80:506–512
Webster DJT, Bronn DG, Minton JP (1978) Estrogen receptors and response of breast cancer to chemotherapy. N Engl J Med 299:604
Westley B, Rochefort H (1979) Estradiol induced proteins in the MCF-7 human breast cancer cell line. Biochem Biophys Res Comm 90:410–416
Wittliff JL, Lewko WM, Park DC, Kute TE, Baker DT, Kane LN (1978) Steroid binding proteins of mammary tissues and their clinical significance in breast cancer. In: McGuire WL (ed) Hormones, receptors and breast cancer. Raven, New York, pp 325–359
Yamamoto KR, Stampfer MR, Tomkins GM (1974) Receptors from glucocorticoid-sensitive lymphoma cells and two classes of insensitive clones: physical and DNA-binding properties. Proc Natl Acad Sci 71:3901–3905
Yamamoto KR, Gehring U, Stampfer MR, Sibley CH (1976) Genetic approaches to steroid hormone action. Recent Prog Horm Res 32:3–32
Young PCM, Einhorn LH, Ehrlich CE, Cleary RE, Rohn RJ (1978) Progesterone receptor as a marker of hormone responsive human breast tumor. Proc Am Assoc Cancer Res 19:204
Zava DT, McGuire WL (1977) Estrogen receptor. Unoccupied sites in nuclei of a breast tumor cell line. J Biol Chem 252:3703–3708
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
IP, M.M. (1984). Steroids. In: Fox, B.W., Fox, M. (eds) Antitumor Drug Resistance. Handbook of Experimental Pharmacology, vol 72. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69490-5_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-69490-5_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69492-9
Online ISBN: 978-3-642-69490-5
eBook Packages: Springer Book Archive